Lower prevalence of lymphatic metastasis and poorer survival of the sentinel node-negative patients limit the prognostic value of sentinel node biopsy for head or neck melanomas

Melanoma Research

Volumn 24, Issue 2, 2014, Pages 158-164

  Al Ghazal, Philipp ^a   Gutzmer, Ralf ^a   Satzger, Imke ^a   Starz, Hans ^b   Bader, Christina ^b   Thoms, Kai Martin ^c   Mitteldorf, Christina ^d   Schön, Michael P ^c   Kapp, Alexander ^a   Bertsch, Hans P ^c   Kretschmer, Lutz ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Klinikum Hildesheim GmbH   (Germany)

Author keywords

Cutaneous melanoma; Head and neck location; Prognostic factor; Sensitivity; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HEAD MELANOMA; HUMAN; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; NECK MELANOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SCHOOL CHILD; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84896404432     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000042     Document Type: Article

References (37)

1. Gutzmer R, Al Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol 2005; 153: 1137-1141.
2. Gomez-Rivera F, Santillan A, McMurphey AB, Paraskevopoulos G, Roberts DB, Prieto VG, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 2008; 30: 1284-1294.
3. Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, et al. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas. J Dtsch Dermatol Ges 2008; 6: 198-203.
4. Saltman BE, Ganly I, Patel SG, Coit DG, Brady MS, Wong RJ, et al. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck 2010; 32: 1686-1692.
5. Goppner D, Ulrich J, Pokrywka A, Peters B, Gollnick H, Leverkus M. Sentinel lymph node biopsy status is a key parameter to stratify the prognostic heterogeneity of malignant melanoma in high-risk tumors >4.0 mm. Dermatology 2011; 222: 59-66.
6. Landi G, Polverelli M, Moscatelli G, Morelli R, Landi C, Fiscelli O, et al. Sentinel lymph node biopsy in patients with primary cutaneous melanoma: study of 455 cases. J Eur Acad Dermatol Venereol 2000; 14: 35-45.
7. Leong SP. Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma. Curr Treat Options Oncol 2004; 5: 185-194.
8. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, et al. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res 2007; 17: 393-399.
9. Parrett BM, Kashani-Sabet M, Singer MI, Li R, Thummala S, Fadaki N, et al. Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg 2012; 147: 699-706.
10. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, et al. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Am J Surg 2011; 202: 659-664, discussion 664-665.
11. Kerr EH, Hameed O, Lewis JS Jr, Bartolucci AA,Wang D, Said-Al-Naief N. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. Int J Surg Pathol 2012; 20: 37-46.
12. Doting EH, de Vries M, Plukker JT, Jager PL, Post WJ, Suurmeijer AJ, et al. Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol 2006; 93: 564-570.
13. Kretschmer L, Starz H, Thoms KM, Satzger I, Völker B, Jung K, et al. Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma. Int J Cancer 2011; 129: 1435-1442.
14. Satzger I, Volker B, Meier A, Schenck F, Kapp A, Gutzmer R. Prognostic significance of isolated HMB45 or melan a positive cells in melanoma sentinel lymph nodes. Am J Surg Pathol 2007; 31: 1175-1180.
15. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and sclassification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004; 11 (3 Suppl): 162S-168S.
16. Garbe C, Schadendorf D, StolzW, Volkenandt M, Reinhold U, Kortmann RD, et al. Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges 2008; 6 (Suppl 1): S9-S14.
17. Balch CM, Gershenwald JE, Soong SJ, Thompson JF. Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol 2011; 104: 379-385.
18. Willis AI, Ridge JA. Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies. Head Neck 2007; 29: 979-985.
19. Macdonald JB, Dueck AC, Gray RJ,Wasif N, Swanson DL, Sekulic A, et al. Malignant melanoma in the elderly: different regional disease and poorer prognosis. J Cancer 2011; 2: 538-543.
20. Tseng WH, Martinez SR. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res 2011; 167: 192-198.
21. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol 2008; 144: 515-521.
22. Wevers KP, Bastiaannet E, Poos HP, van Ginkel RJ, Plukker JT, Hoekstra HJ. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites? Ann Surg Oncol 2012; 19: 3913-3918.
23. Chao C, Wong SL, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003; 10: 21-26.
24. de Wilt JH, Thompson JF, Uren RF, Ka VS, Scolyer RA, McCarthy WH, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004; 239: 544-552.
25. Carlson GW, Murray DR, Greenlee R, Alazraki N, Fry-Spray C, Poole R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg 2000; 126: 433-437.
26. Chao C, Wong SL, Edwards MJ, Ross MI, Reintgen DS, Noyes RD, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg 2006; 132: 370-373.
27. Teltzrow T, Osinga J, Schwipper V. Reliability of sentinel lymph-node extirpation as a diagnostic method for malignant melanoma of the head and neck region. Int J Oral Maxillofac Surg 2007; 36: 481-487.
28. Agnese DM, Maupin R, Tillman B, Pozderac RD, Magro C,Walker MJ. Head and neck melanoma in the sentinel lymph node era. Arch Otolaryngol Head Neck Surg 2007; 133: 1121-1124.
29. Erman AB, Collar RM, Griffith KA, Lowe L, Sabel MS, Bichakjian CK, et al. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 2012; 118: 1040-1047.
30. Miller MW, Vetto JT, Monroe MM,Weerasinghe R, Andersen PE, Gross ND. False-negative sentinel lymph node biopsy in head and neck melanoma. Otolaryngol Head Neck Surg 2011; 145: 606-611.
31. McDonald K, Page AJ, Jordan SW, Chu C, Hestley A, Delman KA, et al. Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma. Head Neck 2013; 35: 667-671.
32. de Rosa N, Lyman GH, Silbermins D, Valsecchi ME, Pruitt SK, Tyler DM, et al. Sentinel node biopsy for head and neck melanoma: a systematic review. Otolaryngol Head Neck Surg 2011; 145: 375-382.
33. Kilpatrick LA, Shen P, Stewart JH, Levine EA. Use of sentinel lymph node biopsy for melanoma of the head and neck. Am Surg 2007; 73: 754-758, discussion 758-759.
34. Kelly J, Fogarty K, Redmond HP. A definitive role for sentinel lymph node mapping with biopsy for cutaneous melanoma of the head and neck. Surgeon 2009; 7: 336-339.
35. Lin D, Franc BL, Kashani-Sabet M, Singer MI. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy. Head Neck 2006; 28: 249-255.
36. Hoetzenecker W, Guenova E, Bottinger TU, Hafner HM, Breuninger H. Mapping of specific sentinel node locations for skin cancer of the head. Eur J Dermatol 2011; 21: 354-358.
37. Stoffels I, Boy C, Pöppel T, Kuhn J, Klötgen K, Dissemond J, et al. Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA 2012; 308: 1007-1014.